Form D Explorer
Vizgen, Inc. · CIK 1790415

Report a data issueCitable research briefCompare issuerPrivate research collection

Vizgen, Inc.

CIK 1790415 · Corporation · Inc. DELAWARE · Waltham, Massachusetts · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
2
Amendments
0
Activity
Oct 7, 2025
through Jan 12, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldOct 7, 2025 · DJan 12, 2026 · DLater minus earlier
Reported offering amount$9,500,000$50,000,000$40,500,000
Reported amount sold$3,500,000$47,788,714$44,288,714
Reported investor count———
Reported minimum investment$0$0$0

Earlier SEC source: 0001790415-25-000005 · Later SEC source: 0001790415-26-000002

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D · Jan 12, 2026

Reported offering amount
$50,000,000
Reported exemptions
Rule 506(b)
Reported amount sold
$47,788,714

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Form D filings (2)